Complexities in Inter-firm R&D Collaborative Partnerships in High-Tech Industries: Innovation and Financial Performances

Governments in both advanced and emerging markets invest heavily into joint R&D projects to facilitate inter-firm collaboration and scientific productivity. As a science-based cluster, nanotechnology is a highly R&D-intensive field with very complex interdisciplinary features that enables multiple interactions between scientists from diverse cultural backgrounds working for multi-faceted organizations across public and private sectors and through internationally regulated borders. In this thesis, I examine the main determinants of the dimensions of inter-firm collaboration in high-tech industries particularly among nanotechnology R&D organisations across Europe. Also, I investigate the key factors that influence the innovation, financial and exit performance of nanotech companies during the commercialisation period and across 15 developed and developing countries, taking into consideration the involvement of venture capital (VC) firms. In order to methodically integrate the qualitative and quantitative features of my research study, I employed mixed method to analyse primary and secondary data collected via survey instruments and comprehensive databases; to gain valuable insights into the complexities around nanotech R&D organisations. The regression results show that a predictable legal system; a high level of tolerance for uncertainty; the proximity to key partners; a high level of export demand for high-tech products; and expansionary economic policies, leads to highly valuable and long-term relationships which produces optimal partnership size with an effective organizational structure. I find that a high financial status of nanotech firms equips R&D project managers with sufficient tangible and intangible resources to engage into complex collaborative partnerships which yield innovative performing outcomes. Also, I find that nanotech R&D firms that exit venture capital investments via IPO are more likely to have their head offices in a big city; and access foreign capital to expand manufacturing operations. I conclude that the successful commercialisation of nanotechnology industries across the globe has been due to the substantial R&D public expenditures and private investments into the application and proliferation of nanotechnologies in key converging scientific fields which require robust inter-firm collaborative partnerships to rapidly develop and promote several portfolios of high-tech products that continually satisfy consumer needs in disruptive ways and secure long-term profitability for nanotech R&D organisations